-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Fulgent Genetics, Inc. annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2018 to Q1 2024.
- Fulgent Genetics, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$557K, a 89.3% increase year-over-year.
- Fulgent Genetics, Inc. annual Deferred Income Tax Expense (Benefit) for 2024 was -$3.74M, a 133% decline from 2023.
- Fulgent Genetics, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was $11.5M.
- Fulgent Genetics, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was -$8.28M, a 1.12% decline from 2021.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)